Drug · DIN 02376660
DIFFERIN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since November 25, 2011.
- Drug Identification Number (DIN)
- 02376660
- Company (DIN owner)
- Galderma Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Lotion
- Route
- Topical
- Therapeutic class (ATC)
- Adapalene D10AD03
- Class
- Human
- Record last updated
- June 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ADAPALENE | 0.1 % |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 25, 2011: NOC 12803Supplement to a New Drug Submission (SNDS) · New Dosage Form - Lotion
Other DINs named DIFFERIN
- DIN 02148749 · Marketed
- DIN 02231592 · Marketed
- DIN 02148757 · Cancelled Post Market